Stayble Therapeutics publishes year-end report for 2022
Stayble Therapeutics AB ("Stayble" or the "Company") hereby publishes its year-end report for 2022. The report is available as an attached document and on the Company's website, https://staybletherapeutics.com/investor-relations/financial-reports/. Below is a summary of the report.Financial information and commentary Stayble Therapeutics AB reported operating expenses of KSEK 4,642 (4,594) for the period October-December 2022. The company had increased costs in the period 1 January to 31 December compared to the previous year. This is directly linked to the positive increase in